Some potential biomarkers include PD-L1 expression, tumor mutational burden (TMB), microsatellite instability/mismatch repair (MSI/MMR) status, Epstein-Barr virus (EBV) infection, circulating tumor DNA (ctDNA), and gut microbiota. Here, CD274 is linked to neoplasm.